Proteonomix, Inc. (OTCPK:PROT)
PROT, a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, announced further developments with its Joint Venture Company, XGEN Medical LLC towards implementing operations in the United Arab Emirates.
PROT is the majority shareholder in XGen with the balance held by an anonymous investor group. PROT personnel were on the ground in the U.A.E. over the past weeks to work together with the Investor Group through the start up phase. To date, XGen has established an office in the Monarch Office Tower on the prestigious Sheikh Zayed Road, and a residence for visiting PROT personnel on Jumeira 2.
During initial meetings, it was mutually decided to open a local subsidiary corporation in the Dubai free zone. This wholly owned subsidiary will be the vehicle to conduct business in the GCC countries. XGen has filed the corporate papers and has established banking relations with a local bank both for receipt of the initial investment of $5 million and towards further financing expanded services in the region. The Ramadan holiday has slowed progress slightly on these corporate formalities, but full operation of the subsidiary and bank accounts are expected to complete within 30 days.
It was further announced that XGen has expanded its talks within the region beyond a license for manufacture of and treatment with PROT cellular material. Discussions are now further encompassing both the construction of XGen's own manufacturing and treatment facility within the U.A.E. and on funding phased trials for one or more of PROT's proprietary cellular materials for treatment of disease.
PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of PROT that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.'s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (NYSE:CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is PROT's operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. PROT intends to create and dedicate a subsidiary to each of its technologies.
To learn more about PROT visit: http://www.proteonomix.com
Albemarle Corporation (NYSE:ALB)
ALB, announced yesterday that it has begun its largest capital investment in the fast growing Asia Pacific region of Yeosu, South Korea.
The Yeosu site contains existing R&D as well as pilot plant equipment that will be modified to enable customer qualification efforts in 2010. The site will effectively mirror Albemarle's world scale metallocene polyolefin catalyst and Trimethyl Gallium (TMG) capabilities located in Baton Rouge, Louisiana.
ALB will build on its leading supply and technology position in metallocene catalysts by leveraging its breakthrough ActivCat technology for polyolefin production. ALB will also leverage its 50+ years of production experience in metal organics to supply High Purity Metal Organics (HPMOs) such as TMG to the High Brightness LED (HBLED) market.
ALB is a global developer, manufacturer and marketer of engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. ALB serves approximately 3,000 customers in over 100 countries. ALB operates through three segments: Polymer Solutions, Catalysts and Fine Chemicals. Polymer Solutions, formerly Polymer Additives, consists of two product market categories: flame retardants and stabilizers and curatives. Catalysts segment includes refinery catalysts and polyolefin catalysts product categories. Fine Chemicals segment consists of two categories: performance chemicals, and fine chemistry services and intermediates. In August 2010, ALB sold its Teesport, the United Kingdom facility to Kemira Oyj. ALB was founded in 1993 and is based in Baton Rouge, Louisiana.
To learn more about ALB visit: http://www.albemarle.com
Alberto-Culver Co. (NYSE:ACV)
During the economic crisis the personal products industry was forced to focus their attention on price reduction in order to move products. The industry fared somewhat better than other non essential goods but brands and high price items suffered. Recently released quarterly earnings have generally shown improvement in the industry, reflecting the upward trend in the economy and a moderate increase in employment. Estee Lauder Companies Inc. second quarter results last week produced profits of $23.9 million whilst ACV saw its profit jumped 69% back in July.
ACV develops, manufactures, distributes and markets beauty care products, as well as food and household products in the United States and approximately 100 other countries. ACV operates in two business segments: United States and International. During the fiscal year ended September 30, 2009 (fiscal 2009), beauty care products accounted for approximately 94% of ACV's consolidated net sales. During fiscal 2009, food and household products accounted for approximately 6% of its consolidated net sales. On April 1, 2009, ACV acquired the remaining 49% minority interest in its subsidiary in Chile. On August 31, 2009, ACV sold its New Zealand subsidiaries, including the BDM Grange distribution business.
To learn more about ACV visit: http://www.alberto.com
ALU yesterday announces that its gigabit passive optical network (GPON) product portfolio is a driving force behind the world's first commercial 1Gbps access networks – enabling service providers across Asia, Europe and North America to deliver to residential and business customers broadband access speeds that revolutionize the way people live and work. Determined to continue to lead this effort, ALU today enlarges its portfolio of GPON-based optical network terminals (ONTs) with five new models - supporting the delivery of 1Gbps services.
ALU provide products, solutions, and transformation services offerings, which enables service providers, enterprises, governments and strategic industries (such as transportation or energy) globally to deliver voice, data and video communication services to the consumers. ALU offers fixed, mobile and converged broadband networking, Internet protocol (NYSE:IP) technologies, applications and services. ALU operates in four business segments: Carrier, Application Software, Enterprise and Services. In May 2009, ALU completed the sale of its 20.8% stake in Thales to Dassault Aviation. On December 31, 2009, ALU completed the sale of of Dunkermotoren GmbH, the electrical fractional horsepower motors and drives subsidiary, to Triton. In July 2009, ALU acquired Velocix, a global provider of content delivery network (CDN) infrastructure and services to Internet and broadband service providers, and media and entertainment companies.
To learn more about ALU visit: http://www.alcatel-lucent.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (OTCPK:PROT)